BETA is published quarterly by the San Francisco AIDS Foundation.

Main page

Subscribe (free)

beta@sfaf.org

Features

Letter from the Editor -- Health, Vision, and Policy

The Global HIV/AIDS Epidemic

Feasible Microbicides Remain Elusive

Issues in HIV Postexposure Prophylaxis

The Wide-Ranging Effects of Nucleoside Analogs: A Look at Mitochondrial Toxicity

Departments

BETA News Briefs

Drug Watch Lopinavir: The Most Potent Protease Inhibitor

Women and HIV Re-Examining Treatment Recommendations for Women Women and HIV/AIDS: Key Facts and Issues

Conference Coverage 3rd International Workshop on Salvage Therapy for HIV Infection

Quick Reference Guides AIDS-Related Web Sites AIDS Drug Assistance Programs by State

Open Clinical Trials

Glossary

Notice

Contributors to this issue

• Kathryn Anastos, MD
• Joshua D. Bamberger, MD, MPH
• Harvey S. Bartnof, MD
• Nicholas Cheonis
• Dave Gilden
• Leslie Hanna
• Liz Highleyman
• Kimberly Page-Shafer, PhD, MPH
• David Townley

Scientific Advisory Committee

• Kirsten Balano, PharmD
• Harvey S. Bartnof, MD
• Gregory Pauxtis, MD
• Mary Romeyn, MD

Copyright

BETA is published quarterly by the San Francisco AIDS Foundation. Funding provided by private and corporate donations. Copyright © 2000 by the San Francisco AIDS Foundation. All rights reserved. Articles may be reproduced for free distribution with acknowledgment of BETA and the author(s); for other uses, contact the editors. Brief passages may be quoted for review. Library of Congress ISSN 1058-708X.

Page last updated 16 August 2000